FDA Expected To Authorize COVID-19 Booster Shots

Phil Roeder / CC BY 2.0

WASHINGTON – The Food and Drug Administration is expected to approve COVID-19 booster shots for immunocompromised people sometime Thursday.

That’s according to a source who is familiar with the ongoing talks.

This will end up being a third shot for the Pfizer and Moderna vaccines which are two-doses each.

The FDA has not officially commented on the issue.

This comes as health officials keep stressing the importance of getting vaccinated against COVID-19.

The Centers for Disease Control and Prevention reports more than 98-percent of Americans live in areas that are considered to have a “high” or “substantial” risk of community transmission of the potentially-deadly virus.


Make it easy to keep up to date with more stories like this. Download the WNY News Now mobile app on the Apple App Store and Google Play Store.


Have a news tip? Email newsdesk@WNYNewsNow.com, send us a message on Facebook, or Twitter.

WNY News Now encourages an open exchange of opinions and ideas on our stories, however, we ask everyone to follow our comment policy.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.